Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02205047
Title Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma (INNOVATION)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors European Organisation for Research and Treatment of Cancer - EORTC
Indications

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma

Therapies

Capecitabine + Cisplatin

Cisplatin + Fluorouracil + Pertuzumab + Trastuzumab

Cisplatin + Fluorouracil

Cisplatin + Fluorouracil + Trastuzumab

Capecitabine + Cisplatin + Trastuzumab

Capecitabine + Cisplatin + Pertuzumab + Trastuzumab

Age Groups: senior | adult
Covered Countries


No variant requirements are available.